BCR ABL（SF）融合基因t（9;22）探針
| 型 號(hào)： | |
| 報(bào) 價(jià)： |  |
BCR ABL（SF）融合基因t（9;22）探針 本試劑盒主要用于BCR ABL（SF）融合基因t（9;22）的檢測(cè)，里面包括即用型雜交液和DAPI復(fù)染劑。 本試劑盒僅供科研使用。
- 產(chǎn)品描述
BCR ABL(SF)融合基因t(9;22)探針
廣州健侖生物科技?有限公司
本司長(zhǎng)期供應(yīng)尼古丁（可替寧）檢測(cè)試劑盒，其主要品牌包括美國(guó)NovaBios、廣州健侖、廣州創(chuàng)侖等進(jìn)口產(chǎn)品，國(guó)產(chǎn)產(chǎn)品，試劑盒的實(shí)驗(yàn)方法是膠體金方法。
我司還有很多熒光原位雜交系列檢測(cè)試劑盒以及各種FISH基因探針和染色體探針等，。
BCR ABL(SF)融合基因t(9;22)探針
本試劑盒主要用于BCR ABL（SF）融合基因t（9;22）的檢測(cè)，里面包括即用型雜交液和DAPI復(fù)染劑。
本試劑盒僅供科研使用。
歡迎咨詢(xún)
歡迎咨詢(xún)
以下是我司出售的部分FISH產(chǎn)品：
| ROS1（6q22）基因斷裂探針 |
| ERCC1（19q13）基因探針 |
| hWAPL（10q23）基因探針 |
| AR基因擴(kuò)增檢測(cè)探針 |
| MDM4（1q32）基因探針 |
| 12號(hào)染色體計(jì)數(shù)探針（綠色） |
| CBFB/MYH11融合基因inv (16), t (16;16)探針 |
| TCF3/ PBX1融合基因t (1;19)探針 |
| ESR1（6q25）基因探針 |
| FGFR1（8p11）基因探針 |
| p53/RB1/ATM/CSP12/D13S25基因探針（獨(dú)立 ） |
| p53/D13S319/RB1/1q21/IGH基因探針（獨(dú)立) |
| NUP98基因斷裂檢測(cè)探針 |
| NTRK1（1q22-q23.1）基因斷裂探針 |
| RET（10q11）基因斷裂探針 |
BCR ABL(SF)融合基因t(9;22)探針
二維碼掃一掃
【公司名稱(chēng)】 廣州健侖生物科技有限公司
【】 楊永漢
【】
【騰訊 】
【公司地址】 廣州清華科技園創(chuàng)新基地番禺石樓鎮(zhèn)創(chuàng)啟路63號(hào)二期2幢101-3室
【企業(yè)文化宣傳】BCR ABL(SF)融合基因t(9;22)探針
Experts point out that the registration system of stock issuance is an important reform direction to promote the real economy of financial services and broaden the source of residents' property income, which is related to the long-term healthy development of capital market and national financial stability. Therefore, to promote the reform of the registration system is not balked, and not rash, but should be combined with the transaction subject, enterprise quality, institutional norms, external risk, market capacity and other aspects of the overall consideration, while maintaining stability. Only in this way can we realize the greatest value of the reform to the economic and social development of China.
Preparatory work effectiveness previews
Compared with the current approval system, registration system requires all listed companies to disclose information fully, fully and truthfully. Regulators only make formal reviews, and focus on the punishment of violation of credit and other behaviors.
China SFC chairman Liu Shiyu said in the description of issues related to the National People's Congress, the past two years, the Commission insist on maintaining stability in the general work guideline, comprehensive measures, take measures to create conditions for the steady advance registration system reform has made positive progress. Specifically, the preparatory work of the reform of the registration system has made six important progress:
One is the market operation mechanism for perfecting the IPO process, IPO "quake lake" effectively alleviate the problem; two is the strict supervision of law enforcement, to increase efforts to crack down on all kinds of illegal behavior; three is to strengthen the exchange of front-line supervision function, to adapt the reform of the registration system in the exchange mechanism required by the system, personnel, experience, ability and other aspects to mature; four is to perfect the accounting firms, law firms, asset appraisal firms and other intermediary supervision, improve the benefit of the reform of the registration system of the market intermediary support system; five is the exploration on the issue of fraud "Xianhengpeifu", improve the delisting system of listed companies, listed companies holdings of shares behavior, improve the supporting institutional arrangements for the reform of the registration system; six is to crack down on fabricating false information spread capital market To create a good environment for public opinion.
"In the past two years, the SFC has made remarkable achievements in information disclosure, illegal punishment, compulsory delisting, new issue and other supporting system construction, thus laying the foundation for the further reform of registration system and creating a market environment. Dong Dengxin, director of the Institute of financial securities, Wuhan University of Science and Technology, said in an interview with the newspaper reporter.
Overall consideration of the same direction
